As a co-founder and general partner of Polaris Partners, Terry McGuire brings more than 25 years of successful early stage investing experience in healthcare and technology companies.
Prior to starting Polaris in 1996, Terry spent 7 years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Terry began his career in venture capital at Golder, Thoma and Cressey in Chicago.
As a venture capitalist, Terry has invested in 48 companies. He also co-founded three companies: Inspire Pharmaceuticals (public), AIR (sold to Alkermes) and MicroCHIPS (private). Terry was recognized by Forbes in 2011, 2013 & 2014.
Terry is emeritus chairman of the National Venture Capital Association, which represents ninety percent of the venture capitalists in the United States. He is also the chairman of Global Venture Capital Congress.
Terry chairs the board of the Thayer School of Engineering, Dartmouth College. He also sits on the boards of MIT’s The David H. Koch Institute for Integrative Cancer Research and The Arthur Rock Center for Entrepreneurship at HBS.
Acceleron Pharma / Adimab / Alector / Arsenal Medical / Iora / Ironwood Pharmaceuticals / Life Line Screening / MicroCHIPS / NextCode Health / Pulmatrix / Quantum Designs / SustainX / Trevena / 480 Biomedical
Forbes Midas List
Massachusetts Society for Medical Research Award
Albert Einstein Award for Outstanding Achievement in Life Sciences
National Venture Capital Association, emeritus Board Chair
Global Venture Capital Congress, Board Chair
Thayer School of Engineering, Dartmouth College, Board Chair
Koch Institute for Integrative Cancer Research, MIT, Board Member
The Arthur Rock Center for Entrepreneurship, HBS, Board Member
Ohio Wesleyan University, honorary Doctorate of Laws
B.S., Hobart College
M.S., Thayer School Engineering, Dartmouth College
M.B.A., Harvard Business School